XYLB2: Key Enzyme in TranSPARTS System (G9942)

Target Name: XYLB

NCBI ID: G9942

XYLB

XYLB2: Key Enzyme in TranSPARTS System

XYLB (ATP:D-xylulose 5-phosphotransferase), also known as XYLB2, is a protein that plays a crucial role in cellular metabolism. It is a key enzyme in the tranSPARTS system, which is responsible for the breakdown of cellulose to produce energy. XYLB2 is highly expressed in most tissues and cells, and its activity has been linked to a wide range of cellular processes, including cell growth, differentiation, and metabolism.

D-xylulose 5-phosphotransferase (XYLB) is an enzyme that plays a key role in the tranSPARTS system, which is responsible for the breakdown of cellulose to produce energy. It is a highly expressed protein in most tissues and cells and has been linked to a wide range of cellular processes.

XYLB2 is a member of the ATP-dependent transcarrier protein (ATP-transporter) family and is expressed in most tissues and cells. It is involved in the transport of various molecules across cell membranes, including ATP, NAD+, FAD, and other co-factors involved in the tranSPARTS system.

The tranSPARTS system is a complex metabolic pathway that is involved in the breakdown of cellulose to produce energy. It is a critical pathway for the production of ATP, which is the primary source of energy for most cellular processes. The tranSPARTS system involves the breakdown of cellulose by the enzyme XYLB2, which is then consumed by the cytosol to produce ATP and other products.

XYLB2 is involved in the initiation of the tranSPARTS pathway by its ability to transfer ATP and other co-factors across the cell membrane. It does this by using a unique ATP-binding site that is located at the interface between the cytosol and the membrane. This site allows XYLB2 to bind to ATP and other co-factors, allowing it to transport them across the membrane and initiate the tranSPARTS pathway.

In addition to its role in the tranSPARTS pathway, XYLB2 is also involved in the regulation of cellular processes. For example, it has been shown to be involved in the regulation of cell growth, differentiation, and metabolism. XYLB2 has been shown to play a role in the regulation of cell size and in the development of cancer. It has also been shown to be involved in the regulation of energy metabolism and in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the aging process.

XYLB2 is also a potential drug target and biomarker. Its role in the tranSPARTS pathway and its involvement in cellular processes make it an attractive target for drug development. XYLB2 has been shown to be involved in the production of various cellular signaling pathways, including the TOR signaling pathway, the PI3K/AKT signaling pathway, and the ERK signaling pathway. Therefore, inhibitors of XYLB2 have been shown to be effective in a variety of cellular models, including cancer, obesity, and diabetes.

In conclusion, XYLB2 is a protein that plays a crucial role in cellular metabolism and has been linked to a wide range of cellular processes. Its role in the tranSPARTS system and its involvement in the regulation of cellular processes make it an attractive target for drug development. Further research is needed to fully understand the role of XYLB2 in cellular processes and its potential as a drug target.

Protein Name: Xylulokinase

Functions: Phosphorylates D-xylulose to produce D-xylulose 5-phosphate, a molecule that may play an important role in the regulation of glucose metabolism and lipogenesis

The "XYLB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XYLB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets